Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Verona Pharma
Verona Pharma
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Verona Pharma gets new CEO and COO
Respiratory-focused biopharma has appointed David Zaccardelli as President and CEO, and Mark Hahn as COO
Verona Pharma makes two senior appointments
Nina Church joins as Executive Director of Global Clinical Development and Nancy Herje as Senior Director of Clinical Operations
Regulatory
Verona gets EU patent for ensifentrine formulation extended to 2035
Drug by the British company is in Phase 2b clinical trials for chronic obstructive pulmonary disease
Recruitment
Verona Pharma announces departure of Chief Medical Officer
Pharmaceutical
Verona Pharma appoints Vice President of Regulatory Affairs
Regulatory
Pharmacokinetic clinical study initiated by Verona Pharma
Verona Pharma initiates US clinical pharmacokinetic study for RPL554 following acceptance of an investigational new drug (IND) application by the US Food and Drug Administration (FDA)
Quintiles outsource Verona COPD and cystic fibrosis therapeutics
Verona Pharma enters global strategic clinical development services agreement with QuintilesIMS for RPL554
Subscribe now